Reaction

Hordeolum reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,156 reports · 146 co-occurring drugs

As of the last recalculation, Hordeolum appears in 4,156 FAERS reports alongside 146 co-occurring drug terms. The strongest observed disproportionality signal is ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR (PRR 31.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Elexacaftor, Tezacaftor, And Ivacaftor	77	31.5	31.7
Cenegermin-Bkbj	63	26.5	26.6
Bimatoprost	101	18.0	18.0
Diphenhydramine Hydrochloride Capsule, Liquid Filled	64	15.2	15.3
Lifitegrast	35	10.8	10.8
Carboxymethylcellulose Sodium	19	10.2	10.2
Infliximab-Dyyb	56	9.7	9.7
Dupilumab	775	9.7	9.7
Human Immunoglobulin G	38	9.3	9.3
Erythromycin	34	9.1	9.2
Mupirocin	23	8.6	8.6
Mupirocin Calcium	23	8.4	8.4
Adrenalinum	67	8.2	8.2
Azelastine	28	7.9	7.9
Bortezomib	132	7.6	7.6
Doxyclycline Hyclate	25	7.4	7.4
Progesterone	29	6.4	6.4
Diphenhydramine	79	6.4	6.4
Cyclobenzaprine Hydrochloride	11	6.1	6.2
Timolol Maleate	12	6.1	6.1
Epinephrine	78	6.1	6.1
Atropine	10	6.1	6.1
Prednisolone Acetate	12	5.8	5.8
Avapritinib	14	5.8	5.8
Thiamine Hydrochloride, Riboflavin 5 Phosphate Sodium, Dexpanthenol And Niacinamide	34	5.7	5.7
Lidocaine	64	5.6	5.6
Thyroid, Porcine	11	5.2	5.2
Zinc Gluconate	26	5.0	5.0
Buspirone Hydrochloride	11	5.0	5.0
Lidicaine	48	5.0	5.0
Burn Relief	48	5.0	5.0
Lidocaine Hydrochloride And Epinephrine	48	5.0	5.0
Dicyclomine Hydrochloride	14	4.9	4.9
Cetirizine Hcl	9	4.9	4.9
Lidocaine, Menthol	48	4.9	4.9
Lidocaine Hydrochloride And Epinephrine Bitartrate	50	4.7	4.7
Triamcinolone Acetonide Ointment Usp, 0.05%	22	4.7	4.7
Zinc	23	4.7	4.7
Zinc Chloride	23	4.7	4.7
Fluticasone Propionate Nasal	28	4.7	4.7
Atropine Sulfate	10	4.6	4.6
Lenalidomide	362	4.6	4.6
Valacyclovir	38	4.6	4.6
Psyllium Husk	9	4.6	4.6
Lidocaine 4%	49	4.5	4.5
Mometasone Furoate And Formoterol Fumarate Dihydrate	14	4.5	4.5
Rosuvastatin Calcium	25	4.5	4.5
Diphenhydramine Hydrochloride	142	4.4	4.4
Biotin	27	4.4	4.4
Lidocaine Hydrochloride	51	4.3	4.3
Methocarbamol Tablets	14	4.2	4.2
Hydroxyzine Hydrochloride	11	4.2	4.2
Hydroxyzine Hydrochloride Oral	11	4.2	4.2
Doxycycline Hyclate	54	4.0	4.0
Doxycycline	54	4.0	4.0
Isotretinoin	39	4.0	4.0
Doxepin	8	4.0	4.0
Brimonidine Tartrate	14	3.9	3.9
Methimazole	6	3.8	3.8
Valacyclovir Hydrochloride	53	3.8	3.8
Triamcinolone Acetonide	23	3.7	3.7
Acyclovir	84	3.7	3.7
Naproxen Sodium, Dextromethorphan Hydrobromide, Guaifenesin	15	3.7	3.7
Naproxen Sodium, Pseudoephedrine Hydrochloride	15	3.7	3.7
Ozanimod Hydrochloride	6	3.6	3.6
Meclizine Hydrochloride	14	3.6	3.6
Tiotropium Bromide Inhalation Spray	8	3.6	3.6
Tobramycin	17	3.6	3.6
Aflibercept	22	3.5	3.5
Brinzolamide	6	3.5	3.5
Dextrose	9	3.4	3.4
Upadacitinib	55	3.4	3.4
Clobetasol Propionate Ointment Usp, 0.05%	7	3.4	3.4
Clobetasol Propionate	7	3.4	3.4
Dextrose Monohydrate	9	3.4	3.4
Levocetirizine Dihydrochloride	16	3.3	3.3
Tobramycin Solution	8	3.3	3.3
Montelukast	55	3.3	3.3
Guaifenesin	20	3.3	3.3
Fluticasone Propionate And Salmeterol Xinafoate	39	3.3	3.3
Ocrelizumab	40	3.3	3.3
Tobramycin Sulfate	8	3.2	3.2
Testosterone	15	3.2	3.2
Ranibizumab	17	3.2	3.2
Dorzolamide Hydrochloride And Timolol Maleate	5	3.2	3.2
Vibegron	5	3.1	3.1
Dornase Alfa	12	3.1	3.1
Bimekizumab	13	3.1	3.1
Ixazomib	17	3.0	3.0
Atorvastatin Calcium, Film Coated	40	2.9	2.9
Polyethylene Glycol 400	7	2.8	2.8
Niraparib	12	2.7	2.7
Dexamethasone	154	2.7	2.7
Dexamethasone 1.5 Mg	152	2.7	2.7
Latanoprost	26	2.6	2.6
Lanreotide Acetate	4	2.6	2.6
Fexofenadine Hydrochloride	11	2.5	2.5
Timolol	6	2.5	2.5
Ruxolitinib	35	2.5	2.5
Ixekizumab	18	2.4	2.4
Rimegepant Sulfate	6	2.4	2.4
Vedolizumab	40	2.3	2.3
Selinexor	4	2.3	2.3
Voclosporin	4	2.3	2.3
Testosterone Cypionate	4	2.2	2.2
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	18	2.2	2.2
Peginterferon Alfa-2A	23	2.1	2.1
Trametinib	10	2.1	2.1
Emicizumab	5	2.0	2.0
Botulinum Toxin Type A	5	2.0	2.0
Pomalidomide	40	2.0	2.0
Ribavirin	25	2.0	2.0
Ivacaftor	3	1.9	1.9
Canakinumab	4	1.9	1.9
Diclofenac Potassium, Film Coated	3	1.8	1.8
Diclofenac Potassium Tablets	3	1.8	1.8
Vortioxetine	6	1.8	1.8
Daratumumab	14	1.8	1.8
Vigabatrin	5	1.7	1.7
Abaloparatide	10	1.7	1.7
Onabotulinumtoxina	26	1.7	1.7
Fingolimod Hcl	29	1.7	1.7
Bosutinib	3	1.7	1.7
Vemurafenib	4	1.7	1.7
Dabrafenib	7	1.7	1.7
Risankizumab-Rzaa	27	1.7	1.7
Secukinumab	53	1.7	1.7
Crisaborole	3	1.6	1.6
Sarilumab	8	1.5	1.5
Ofatumumab	10	1.5	1.5
Pseudoephedrine Hydrochloride	3	1.5	1.5
Certolizumab Pegol	34	1.5	1.5
Budesonide, Glycopyrrolate, And Formoterol Fumarate	3	1.4	1.4
Guselkumab	10	1.4	1.4
Pseudoephedrine Hcl	3	1.4	1.4
Benralizumab	5	1.3	1.3
Nirmatrelvir And Ritonavir	13	1.2	1.2
Dalfampridine	17	1.2	1.2
Nemolizumab-Ilto	3	1.2	1.2
Relugolix	5	1.1	1.1
Osimertinib	6	0.9	0.9
Apremilast	24	0.8	0.8
Galcanezumab-Gnlm	5	0.8	0.8
Evolocumab	18	0.6	0.6
Cinacalcet Hydrochloride	5	0.5	0.5
Adapalene	8	0.2	0.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.